✦ LIBER ✦

Efficacy and safety of atorvastatin in hyperlipidemic, type 2 diabetic patients. A 34-week, multicenter, open-label study

✍ Scribed by Carlos A. Aguilar-Salinas; Francisco J. Gómez-Pérez; Carlos Posadas-Romero; Cuauhtémoc Vázquez-Chávez; Eduardo Meaney; Alfonso Gulı́as-Herrero; Luz E. Guillén; Alma Alvarado Vega; Enrique Mendoza Pérez; Luis Eduardo Romero-Nava; Rita Angélica Gómez-Dı́az; Saúl Salinas-Orozco; Rafael Moguel; Germán Novoa

Book ID: 119438794
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 156 KB
Volume: 152
Category: Article
ISSN: 0021-9150
DOI: 10.1016/s0021-9150(99)00502-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of atorvastatin 10 mg/d on insul

Effects of atorvastatin 10 mg/d on insulin resistance: A 12-week, open-label study in hyperlipidemic patients

✍ Filiz Özerkan; Öner Özdogan; Mehdi Zoghi; Sanem Nalbantgil; Oğuz Yavuzgil; M. Re 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 683 KB

Efficacy of benfluorex in combination wi

Efficacy of benfluorex in combination with sulfonylurea in type 2 diabetic patients: An 18 to 34-week, open-label, extension period

✍ P. Moulin; M. André; H. Alawi; L.C. Dos Santos; A.K. Khalid; D. Koev; R. Moore; 📂 Article 📅 2009 🏛 Masson Editeur 🌐 French ⚖ 588 KB

A multicenter, open-label, efficacy, pha

A multicenter, open-label, efficacy, pharmacokinetic, and safety study of adalimumab in Japanese patients with ankylosing spondylitis

✍ Shigeto Kobayashi,Masayoshi Harigai,Neelufar Mozaffarian… 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 261 KB

The efficacy and safety of terlipressin

The efficacy and safety of terlipressin and albumin in patients with type 1 hepatorenal syndrome: a multicenter, open-label, explorative study

✍ Yoshiyuki Narahara; Hidenori Kanazawa; Choitsu Sakamoto; Hitoshi Maruyama; Osamu 📂 Article 📅 2011 🏛 Springer Japan 🌐 English ⚖ 241 KB

Efficacy and safety of atorvastatin vers

Efficacy and safety of atorvastatin versus simvastatin in mixed dyslipidemic patients with and without type 2 diabetes during 54 weeks

✍ Insull, W.; Kafonek, S.; Goldner, D.B.; Zieve, F. 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 126 KB

Efficacy and tolerability of olanzapine

Efficacy and tolerability of olanzapine in patients with schizophrenia in lithuania: A 13-week, multicenter, open-label, nonrandomized study

✍ Valentinas Maciulis; Istvan Bitter; Raimundas Milasiunas; Algirdas Dembinskas; L 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 724 KB